vimarsana.com

Page 6 - நிறுவனம் க்கு அமைப்புகள் உயிரியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MEDIA ALERT: Dr David Sinclair on Why We Age – And Why We Don t Have To

MEDIA ALERT: Dr. David Sinclair on Why We Age – And Why We Don’t Have To Share Article Harvard Medical School Professor Dr. David Sinclair will join ISB Co-founder and genomics pioneer Dr. Lee Hood for a livestream conversation on Thursday, April 15, at 9 p.m. ET/6 p.m. PT. Harvard Medical School Professor Dr. David Sinclair, left, and ISB Co-founder and legendary biologist Dr. Lee Hood will discuss the very latest in aging research on Thursday, April 15, at 6 p.m. PT. “Aging isn’t inevitable, but it is the key to slowing all diseases.” – ISB Co-founder Dr. Lee Hood SEATTLE (PRWEB)

Second Opinion: Getting past disease to the science of wellness

Second Opinion: Getting past disease to the science of wellness
latimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from latimes.com Daily Mail and Mail on Sunday newspapers.

Future of the Microbiome Brings Together the Most Visionary Minds in the Category for 3-day Inaugural Summit March 23-25, 2021

Day One highlights Microbiome through life: Exploring new science and commercial strategies from the first 1,000 days to healthy aging. The day features Francesco Asnicar, University of Trento; John Deaton, Deerland Probiotics & Enzymes; Jennifer Gu, AIDP, Inc; Lindsay Hall, Quadram Institute and the Technical University of Munich; David Kyle, Evolve BioSystems, Inc.; Stephen Lindemann, Purdue University and Nathan Price, Institute for Systems Biology and Onegevity Health. Day Two will look at New opportunities and developing ideas in the science and business of the microbiome and will feature experts such as Mariette Abrahams, Qina; Charles Budinoff, IFF; Noah Voreades, GenBiome Consulting; Paul Wilmes, Luxembourg Centre for Systems Biomedicine; Mark Wright, Health Wright Products and Hariom Yadav, Wake Forest University

Novel method can improve the detection of circulating tumor cells

Novel method can improve the detection of circulating tumor cells Non-Small Cell Lung Cancer (NSCLC) is the most prevalent form of lung cancer, accounting for more than 80 percent of all lung cancer cases. Despite the aggressive nature of NSCLC, circulating tumor cells that lead to metastases often go undetected in the blood compared to breast, prostate, colorectal, and other cancers. Now, scientists have developed a novel method to better detect the circulating tumor cells (CTCs) that are a telltale sign of metastases. The research was published in the journal Proceedings of the National Academy of Sciences ( PNAS). ISB and a collaborative team of researchers looked at hexokinase-2, or HK2, a key enzyme in glucose metabolism. A set of previous reports from our collaborator Dr. Herschman (co-author of the paper) and others revealed that cancer cells often rely on HK2 to elevate glucose metabolism to fuel their uncontrolled growth, making this enzyme a desirable target for test

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.